This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
486 |
4. Check minimum number of eventsNone |
486 |
5. Include endpointsNone |
486 |
6. Filter based on genotype QC (FinnGen only) |
466 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Somnolence
based on the number of shared cases.
Similar with more cases:
- Somnolence, stupor and coma
- Condition for Implicit Sepsis (Organ dysfunction codes)
- Symptoms and signs involving cognition, perception, emotional state and behaviour
- Condition for Implicit Sepsis (Organ dysfunction codes)
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 466 | 273 | 193 |
| Unadjusted period prevalence (%) | 0.09 | 0.10 | 0.09 |
| Median age at first event (years) | 50.44 | 44.50 | 58.85 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 486
- Matched controls
- 4860
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R40.0
ICD-10 Finland
Somnolence
+∞
307.7
486
*
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
8.9
62.7
86
115
R53
ICD-10 Finland
Malaise and fatigue
4.2
53.3
221
799
F32.9
ICD-10 Finland
Depressive episode, unspecified
4.8
48.1
136
365
R56.8
ICD-10 Finland
Other and unspecified convulsions
7.2
43.5
70
111
N06AX16
ATC
venlafaxine; oral
4.4
43.4
136
393
N03AG01
ATC
valproic acid; systemic, rectal
6.2
42.0
79
147
T36
ICD-10 Finland
Poisoning by systemic antibiotics
7.2
40.3
64
100
AA1AD
NOMESCO Finland
CT of head and brain
3.7
40.2
185
696
N05AH04
ATC
quetiapine; oral
3.7
37.1
162
584
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.5
37.1
105
278
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
7.7
31.9
47
67
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
4.9
30.5
75
176
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
4.5
30.3
84
217
TAB00
NOMESCO Finland
Lumbar puncture
6.2
30.3
55
98
N03AE01
ATC
clonazepam; systemic
6.0
29.1
55
102
N03AX09
ATC
lamotrigine; oral
5.5
27.5
57
115
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
5.7
27.4
54
104
N06AB04
ATC
citalopram; systemic
3.1
27.1
149
605
N05AA02
ATC
levomepromazine; systemic
5.9
25.6
48
88
G47.9
ICD-10 Finland
Sleep disorder, unspecified
7.2
25.4
39
58
G40.9
ICD-10 Finland
Epilepsy, unspecified
6.7
25.3
42
68
N05BA01
ATC
diazepam; systemic, rectal
3.5
25.0
102
344
N03AX16
ATC
[U] pregabalin
3.0
24.6
146
615
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
4.4
24.4
67
171
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
4.5
23.7
62
152
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.2
22.6
105
382
N06AX21
ATC
duloxetine; oral
3.4
22.3
93
317
N06AX12
ATC
bupropion; oral
3.9
22.2
72
207
R42
ICD-10 Finland
Dizziness and giddiness
2.8
21.9
138
596
G47.1
ICD-10 Finland
Disorders of excessive somnolence [hypersomnias]
120.5
21.8
23
*
N05AH03
ATC
olanzapine; systemic
4.2
21.7
63
167
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
9.4
21.4
26
29
Z2445
NOMESCO Finland
Psychologist
4.8
21.3
51
116
N05AX08
ATC
risperidone; systemic
3.6
21.1
76
235
R51.80
ICD-10 Finland
Headache
2.9
20.9
123
510
A06AD11
ATC
lactulose; oral
3.1
20.9
105
399
N05AF03
ATC
chlorprothixene; systemic
6.7
20.4
33
52
G47.4
ICD-10 Finland
Narcolepsy and cataplexy
60.2
20.1
23
*
G47.3
ICD-10 Finland
Sleep apnoea
2.7
19.4
134
602
N05AX12
ATC
aripiprazole; systemic
4.9
19.3
45
100
N06AA09
ATC
amitriptyline; systemic
3.7
19.3
68
207
N05AD01
ATC
haloperidol; systemic
6.1
19.1
34
59
N06AB03
ATC
fluoxetine; oral
3.1
19.1
89
323
N06AB06
ATC
sertraline; oral
3.1
18.9
90
330
A04
ICPC
Weakness/tiredness general
2.9
18.9
104
414
Z3231
NOMESCO Finland
Registered nurse
2.5
18.7
171
878
R55
ICD-10 Finland
Syncope and collapse
3.3
18.6
79
271
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.5
18.5
47
112
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.9
18.5
100
394
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.5
18.5
70
223
XA800
NOMESCO Finland
Neuropsychological investigation
4.7
18.4
45
104
R41.0
ICD-10 Finland
Disorientation, unspecified
6.2
18.1
32
55
Z2446
NOMESCO Finland
Social worker
3.7
18.1
63
190
N06AX11
ATC
mirtazapine; oral
2.4
18.1
195
1074
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.9
18.0
56
156
Z3226
NOMESCO Finland
Physiotherapist
2.7
17.8
119
524
Z2221
NOMESCO Finland
Medical doctor
2.4
17.7
168
872
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.4
17.7
36
71
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
17.6
156
786
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
4.2
17.5
49
126
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
3.3
17.3
71
238
N05CD07
ATC
temazepam; oral
3.1
17.1
79
284
G47.2
ICD-10 Finland
Disorders of the sleep-wake schedule
52.0
17.1
20
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
7.8
17.1
24
32
P76
ICPC
Depressive disorder
3.6
16.9
59
178
N03AX11
ATC
topiramate; oral
6.1
16.9
30
52
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.3
16.8
212
1239
S06.0
ICD-10 Finland
Concussion
3.0
16.7
84
317
ZY010
NOMESCO Finland
Hospital outpatient
3.8
16.6
54
155
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
16.5
87
337
N04BC05
ATC
pramipexole; oral
3.6
16.3
57
172
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.4
16.2
63
204
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.8
16.0
96
398
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
15.8
145
737
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.5
15.6
125
597
E86
ICD-10 Finland
Volume depletion
7.0
15.4
24
36
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.1
15.4
72
260
N03AX12
ATC
[U] gabapentin; oral
2.7
15.3
99
426
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
15.1
121
577
F10.09
ICD-10 Finland
Alcohol intoxication UNS
6.0
15.1
27
47
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.8
15.1
87
353
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
5.0
14.9
33
70
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
14.8
215
1312
C07AB07
ATC
bisoprolol; oral
2.1
14.8
227
1415
N05AB03
ATC
perphenazine; systemic, rectal
5.0
14.7
32
67
F10.20
ICD-10 Finland
Alcohol dependence currently independent
6.8
14.6
23
35
R4110
NOMESCO Finland
Physiotherapy
2.2
14.0
150
808
N06AX03
ATC
mianserin; oral
4.2
13.9
38
96
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.1
13.7
62
219
C03CA01
ATC
furosemide; systemic
2.2
13.6
153
839
N05BA04
ATC
oxazepam; oral
2.2
13.6
153
839
N06AB10
ATC
escitalopram; oral
2.3
13.6
136
711
L28
ICPC
Limited function/disability (L)
2.6
13.5
93
412
N05BA06
ATC
lorazepam; systemic, sublingual
3.8
13.4
42
117
A28
ICPC
Limited function/disability NOS
2.6
13.3
92
407
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.1
13.3
166
947
N05CF01
ATC
zopiclone; oral
2.1
13.3
169
972
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.3
13.2
54
180
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
5.2
13.0
27
54
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
6.4
13.0
22
36
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
4.3
13.0
34
83
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
4.6
12.8
31
71
WX892
NOMESCO Finland
Monitored bed care
3.3
12.7
51
168
XF400
NOMESCO Finland
ECG with 12 standard connections
2.5
12.7
89
397
F34.1
ICD-10 Finland
Dysthymia
4.1
12.6
36
94
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.1
12.5
55
191
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.3
12.3
106
518
N02AX02
ATC
tramadol; systemic, rectal
2.0
12.2
209
1331
N05CF02
ATC
zolpidem; oral
2.4
12.1
93
432
N06BA07
ATC
modafinil; oral
22.0
12.1
17
8
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
6.1
11.9
21
36
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.5
11.9
80
349
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
4.8
11.8
27
59
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.6
11.8
76
325
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
4.0
11.7
34
90
R50.9
ICD-10 Finland
Fever, unspecified
2.4
11.6
91
426
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.5
11.4
79
349
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
5.3
11.4
23
45
F33
ICD-10 Finland
Recurrent depressive disorder
4.9
11.3
25
53
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
4.1
11.3
32
83
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
17.6
11.3
17
10
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.1
11.3
132
729
N06AB05
ATC
paroxetine; oral
3.4
11.2
42
132
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.2
11.1
45
149
UKC02
NOMESCO Finland
Cystoscopy
2.4
11.0
83
382
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.4
10.9
88
417
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.2
10.8
43
141
R11
ICD-10 Finland
Nausea and vomiting
2.7
10.8
62
250
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
10.7
110
576
N05AN01
ATC
lithium; oral
4.8
10.6
24
52
A46
ICD-10 Finland
Erysipelas
2.4
10.6
77
348
N06AX18
ATC
reboxetine; oral
14.6
10.6
17
12
N07BB01
ATC
disulfiram; oral
3.8
10.5
33
92
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
5.3
10.4
21
41
K59.1
ICD-10 Finland
Functional diarrhoea
3.5
10.3
37
113
N06AX26
ATC
vortioxetine; oral
2.9
10.2
51
191
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.8
10.1
31
85
K59.09
ICD-10 Finland
Constipation, unspecified
3.2
10.1
41
136
G43.9
ICD-10 Finland
Migraine, unspecified
2.9
10.0
48
175
L03
ICPC
Low back symptom/complaint
2.0
9.9
142
838
R07.4
ICD-10 Finland
Chest pain, unspecified
2.0
9.9
134
775
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
9.9
130
744
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.0
9.8
45
160
R02
ICPC
Shortness of breath/dyspnoea
2.4
9.7
69
308
H02AB06
ATC
prednisolone; systemic
1.8
9.7
224
1544
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
9.6
62
264
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.2
9.6
98
510
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.4
9.6
71
323
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
3.7
9.5
30
84
R40
ICD-10 Finland
Somnolence, stupor and coma
101.9
9.4
10
*
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
4.1
9.4
26
66
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
5.3
9.4
19
37
R06.5
ICD-10 Finland
Mouth breathing
2.7
9.4
54
217
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.2
9.4
86
428
N06AX22
ATC
agomelatine; oral
4.7
9.4
22
49
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.9
9.4
46
170
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.4
9.4
35
110
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
9.3
175
1126
WX730
NOMESCO Finland
Conventional respirator
14.0
9.2
15
11
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.7
9.2
51
201
P03
ICPC
Feeling depressed
2.4
9.2
70
322
G44.2
ICD-10 Finland
Tension-type headache
2.2
9.2
82
404
N05AH02
ATC
clozapine; systemic
4.6
9.2
22
50
N04AA02
ATC
biperiden; systemic
5.2
9.2
19
38
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
5.2
9.2
19
38
N05BA02
ATC
chlordiazepoxide; systemic
5.2
9.2
19
38
F10.25
ICD-10 Finland
Alcohol dependence continuous use
8.5
9.1
19
23
N06BA04
ATC
methylphenidate; oral
3.3
9.1
35
112
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.2
9.1
24
59
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.7
9.1
52
209
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.7
9.1
51
203
N02BF02
ATC
pregabalin; oral
3.2
9.0
36
118
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
9.0
181
1188
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.5
9.0
57
241
A02BC05
ATC
esomeprazole; systemic
1.8
9.0
188
1250
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.1
8.8
37
125
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
7.4
8.8
20
28
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
4.3
8.8
23
56
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.6
8.8
55
231
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.5
8.8
58
250
R06AE07
ATC
cetirizine; oral
1.8
8.8
215
1495
A02BC02
ATC
pantoprazole; systemic
1.8
8.7
306
2359
M79.6
ICD-10 Finland
Pain in limb
1.8
8.7
201
1371
N03AF02
ATC
oxcarbazepine; oral
3.9
8.7
26
70
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
3.8
8.7
27
75
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
8.7
104
574
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.8
8.6
44
166
N05AF05
ATC
zuclopenthixol; systemic
10.3
8.6
16
16
N06AX05
ATC
trazodone; oral
4.3
8.5
22
53
S01.0
ICD-10 Finland
Open wound of scalp
2.8
8.5
45
173
A01
ICPC
Pain general/multiple sites
2.7
8.5
49
197
RS221, ,
NOMESCO Finland
7.6
8.5
19
26
G41.9
ICD-10 Finland
Status epilepticus, unspecified
20.5
8.5
12
6
AA40B, ,
NOMESCO Finland
20.5
8.5
12
6
X59
ICD-10 Finland
Exposure to unspecified factor
2.0
8.5
101
556
R60.0
ICD-10 Finland
Localized oedema
2.4
8.4
61
274
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.8
8.4
42
157
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
8.8
8.4
17
20
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.8
8.4
44
169
N01
ICPC
Headache
2.2
8.3
80
405
R40.2
ICD-10 Finland
Coma, unspecified
9.7
8.3
16
17
C07AA05
ATC
propranolol; systemic
2.0
8.3
112
644
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
3.8
8.3
25
68
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.3
8.3
32
103
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
8.3
210
1469
N05BA09
ATC
clobazam; oral
14.8
8.2
13
9
M79.7
ICD-10 Finland
Fibromyalgia
3.7
8.2
26
73
IGY99
NOMESCO Finland
Other psychiatric treatment contact
4.1
8.2
22
55
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
4.1
8.2
22
55
F29
ICD-10 Finland
Unspecified nonorganic psychosis
3.2
8.1
32
104
R60.9
ICD-10 Finland
Oedema, unspecified
3.3
8.1
31
99
R06.0
ICD-10 Finland
Dyspnoea
1.9
8.1
129
783
IGY02
NOMESCO Finland
Psychiatric monitoring contact
3.5
8.1
28
84
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.5
8.0
53
228
R4120
NOMESCO Finland
Occupational therapy
2.8
8.0
41
155
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
8.0
123
737
D12
ICPC
Constipation
3.7
8.0
25
70
S18
ICPC
Laceration/cut
1.7
7.9
204
1428
P29
ICPC
Psychological sympt/compl other
2.5
7.8
51
218
P99
ICPC
Psychological disorders other
3.8
7.8
24
66
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
4.6
7.7
18
40
Z50.1
ICD-10 Finland
Other physical therapy
3.1
7.7
32
108
N30.0
ICD-10 Finland
Acute cystitis
2.1
7.6
85
455
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.0
7.6
34
119
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.4
7.6
28
87
F43.1
ICD-10 Finland
Post-traumatic stress disorder
3.5
7.6
26
77
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
6.3
7.6
19
31
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.9
7.6
22
58
N05BA12
ATC
alprazolam; oral
2.4
7.6
55
247
Z71.8
ICD-10 Finland
Other specified counselling
1.8
7.5
157
1031
L17
ICPC
Foot/toe symptom/complaint
1.8
7.5
136
857
J01MA02
ATC
ciprofloxacin; systemic
1.7
7.5
176
1196
N03AX14
ATC
levetiracetam; systemic
4.5
7.5
18
41
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
6.6
7.5
18
28
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
6.1
7.4
19
32
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
7.8
7.4
16
21
P77
ICPC
Suicide/suicide attempt
81.3
7.4
8
*
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.9
7.4
22
59
R00.2
ICD-10 Finland
Palpitations
2.6
7.4
45
186
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.9
7.4
35
127
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.8
7.4
139
886
K07
ICPC
Swollen ankles/oedema
3.5
7.3
25
74
R25.1
ICD-10 Finland
Tremor, unspecified
4.3
7.3
19
46
F61.0
ICD-10 Finland
Mixed personality disorders
6.4
7.3
18
29
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
7.3
96
545
U04
ICPC
Incontinence urine
3.2
7.3
29
95
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.4
7.3
18
42
L12
ICPC
Hand/finger symptom/complaint
2.0
7.3
87
478
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
4.6
7.2
17
38
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.4
7.2
53
240
F10.05
ICD-10 Finland
Alcohol-related acute intoxication with coma
30.5
7.2
9
*
F05.8
ICD-10 Finland
Other delirium
20.4
7.2
10
5
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
8.1
7.2
15
19
R13
ICD-10 Finland
Dysphagia
2.8
7.1
37
141
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.1
7.1
68
343
TKC20
NOMESCO Finland
Catheterisation of bladder
2.7
7.1
40
159
N06AX17
ATC
milnacipran; oral
10.2
7.1
13
13
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.6
7.1
42
172
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.1
7.0
29
97
C03DA01
ATC
spironolactone; oral
2.3
7.0
57
269
N06AA12
ATC
doxepin; systemic
2.8
7.0
34
125
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
4.5
7.0
17
39
WX402
NOMESCO Finland
General anaesthesia
1.9
7.0
98
568
SPAT1254
SPAT
Administration of medicine
2.0
7.0
79
425
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.4
7.0
51
230
SPAT1216
SPAT
Assessment of functional ability
2.1
7.0
69
353
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.3
6.9
56
264
N03AX18
ATC
lacosamide; systemic
14.0
6.9
11
8
F20.9
ICD-10 Finland
Schizophrenia, unspecified
4.2
6.9
18
44
F32
ICD-10 Finland
Depressive episode
2.7
6.8
36
139
WX290, ,
SPAT
3.4
6.8
24
73
H03AA01
ATC
levothyroxine sodium; systemic
1.8
6.7
109
661
H53.1
ICD-10 Finland
Subjective visual disturbances
2.7
6.7
37
146
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.7
6.7
37
146
E66.8
ICD-10 Finland
Other obesity
2.9
6.7
32
117
I50.9
ICD-10 Finland
Heart failure, unspecified
2.1
6.7
68
352
F32.1
ICD-10 Finland
Moderate depressive episode
2.4
6.6
44
190
F31.8
ICD-10 Finland
Other bipolar affective disorders
4.3
6.6
17
41
C07AB02
ATC
metoprolol; systemic
1.9
6.6
92
532
S97
ICPC
Chronic ulcer skin
2.8
6.6
32
118
B01AA03
ATC
warfarin; systemic
1.9
6.6
84
472
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
3.0
6.5
28
96
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
6.5
137
897
N05BE01
ATC
buspirone; oral
3.6
6.5
21
60
R06.4
ICD-10 Finland
Hyperventilation
5.8
6.5
17
30
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.1
6.4
26
86
R5140
NOMESCO Finland
Monitoring the use of the aid
2.2
6.4
54
259
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
3.7
6.4
20
56
I50.1
ICD-10 Finland
Left ventricular failure
3.0
6.4
27
92
N02CC06
ATC
eletriptan; oral
3.4
6.4
23
71
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.3
6.3
48
220
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.2
6.3
57
281
F03
ICD-10 Finland
Unspecified dementia
3.1
6.3
26
87
L29
ICPC
Musculoskeletal sympt/complt other
2.4
6.3
43
188
WX002
NOMESCO Finland
Sedation and analgesia
1.9
6.3
86
494
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.7
6.3
34
133
WVA20
NOMESCO Finland
Medicine administration
3.8
6.3
19
52
ZXD05
NOMESCO Finland
Urgent procedure
1.7
6.2
152
1034
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
4.1
6.2
17
43
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.0
6.2
70
376
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
3.1
6.2
25
83
ZXE00
NOMESCO Finland
One hour or less
1.6
6.2
182
1301
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
3.9
6.1
18
48
R32
ICD-10 Finland
Unspecified urinary incontinence
4.2
6.1
16
39
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.4
6.1
41
178
N06DA03
ATC
rivastigmine; oral, transdermal
3.3
6.1
23
73
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
6.1
100
608
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.1
6.1
58
293
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
3.0
6.0
27
95
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
4.0
6.0
17
44
D02
ICPC
Abdominal pain epigastric
2.7
6.0
33
130
U71
ICPC
Cystitis/urinary infection other
2.7
6.0
33
130
N17
ICPC
Vertigo/dizziness
2.1
6.0
56
280
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
51
77
7.28
32.95
2.8
4.7
33.41
37.77
umol/l
0.45
44
71
284
1658
2.72
25.43
11.7
6.9
1.21
1.21
mmol/l
0.85
257
1414
202
1013
2.70
24.31
4.4
2.1
368.98
266.79
u/l
0.30
189
964
260
1492
2.60
23.52
11.7
6.3
1.21
1.21
mmol/l
0.71
248
1366
43
79
5.87
22.85
1.4
1.8
4.02
3.60
mmol/l
1.27
38
72
109
422
3.04
21.01
8.4
6.4
1.08
1.05
mmol/l
0.62
103
390
85
307
3.14
18.32
5.5
5.0
2.19
1.59
mmol/l
0.73
74
239
129
588
2.63
18.02
2.0
1.7
1169.93
1177.18
nmol/l
0.03
98
447
92
352
2.99
17.92
11.7
8.6
2.07
1.06
mmol/l
1.48
71
282
39
83
5.02
17.60
1.8
1.8
4.06
7.49
e6/l
0.39
34
63
235
1422
2.26
17.20
6.7
4.9
35.21
36.15
g/l
1.90
221
1335
214
1249
2.27
17.06
3.9
3.2
28.94
30.33
u/l
0.42
207
1198
223
1335
2.24
16.59
2.6
1.8
95.34
94.07
pmol/l
0.15
128
693
179
983
2.30
16.37
5.2
3.1
0.45
0.40
e6/l
0.10
141
741
89
353
2.86
16.15
1.8
1.9
393.37
382.91
nmol/l
0.13
82
326
75
273
3.07
15.86
8.7
7.9
8.75
8.51
mmol/l
0.10
68
262
275
1827
2.16
15.35
6.7
5.9
11.32
11.52
umol/l
0.06
265
1724
117
548
2.49
15.19
3.4
2.3
13.05
13.41
umol/l
0.20
112
514
72
266
3.00
14.80
5.0
4.7
4.94
4.58
kpa
0.76
67
257
144
751
2.30
14.62
4.3
2.6
4.84
6.46
e6/l
0.70
128
679
166
922
2.22
14.45
2.6
2.0
2.81
2.89
mg/l
0.19
150
793
114
541
2.45
14.31
4.9
3.7
0.81
0.82
mmol/l
0.06
101
510
206
1249
2.13
14.30
5.3
3.3
—
—
—
0
0
152
837
2.19
13.35
2.1
1.9
1.08
1.07
mg/l
0.01
114
626
100
465
2.45
13.03
3.7
2.3
22.30
23.14
%
0.21
90
410
73
294
2.75
12.75
13.3
9.4
118.37
121.65
g/l
0.62
73
286
329
2434
2.09
12.74
7.5
4.3
9.50
3531.98
e6/l
—
6
44
123
634
2.26
12.62
5.0
3.4
128.32
284.96
ng/l
0.74
90
456
230
1503
2.01
12.58
2.9
2.3
73.79
74.52
nmol/l
0.15
217
1357
291
2074
2.00
12.32
9.8
4.9
6.64
6.52
mmol/l
0.42
277
1906
181
1094
2.04
12.25
5.3
3.3
24.28
135.70
e6/l
1.14
141
844
114
578
2.27
12.12
3.8
2.9
0.73
1.00
e6/l
0.96
62
327
84
383
2.44
11.33
2.3
1.8
—
—
—
0
0
77
339
2.51
11.19
3.2
2.5
29.76
32.79
u/l
0.29
59
282
353
2743
2.05
11.12
9.5
6.9
78.41
78.40
u/l
0.00
340
2570
83
380
2.43
11.09
2.4
1.9
—
—
—
0
0
60
235
2.77
11.01
3.9
4.3
104.73
77.82
ng/l
0.83
52
213
227
1533
1.90
10.78
19.6
12.5
1.25
1.22
inr
0.20
71
492
184
1161
1.94
10.72
3.3
3.0
2.35
2.35
mmol/l
0.02
166
1045
102
520
2.22
10.59
2.4
1.8
1.47
1.44
%
0.28
95
464
53
201
2.84
10.32
4.9
4.2
123.57
129.20
g/l
1.23
53
196
88
428
2.29
10.21
3.2
3.1
5.79
8.30
umol/l
0.97
75
362
253
1806
1.84
9.77
7.2
5.9
28.81
28.72
%
0.05
243
1708
104
552
2.12
9.70
2.5
1.9
—
—
—
0
0
250
1789
1.82
9.48
6.8
5.6
56.54
56.73
%
0.09
239
1689
104
557
2.10
9.45
3.9
3.1
1.13
2.70
e6/l
2.44
52
304
173
1106
1.88
9.44
4.1
2.6
53.95
58.15
u/l
0.67
163
1025
54
221
2.62
9.08
1.9
1.5
—
—
—
0
0
358
2892
1.90
8.83
5.2
3.9
14.13
14.51
pmol/l
2.45
334
2639
249
1809
1.77
8.72
4.2
2.7
85.85
98.65
ug/l
0.87
235
1689
64
290
2.39
8.68
1.9
2.7
0.21
0.22
g/l
0.51
55
270
131
786
1.91
8.57
1.9
1.5
21.19
20.83
nmol/l
0.09
123
674
26
73
3.71
8.24
3.1
2.4
124.55
130.96
g/l
0.59
20
53
282
2151
1.74
8.08
11.5
8.9
4.06
4.11
e9/l
0.13
254
1875
107
616
1.95
7.85
3.4
2.7
2.44
2.44
mmol/l
0.18
85
536
338
2740
1.77
7.55
4.8
3.8
11.52
10.66
mm/h
0.62
324
2535
117
704
1.87
7.48
1.8
1.7
108911372.73
22130216.09
pmol/l
0.36
101
601
106
620
1.91
7.38
1.3
1.3
17.15
27.40
iu/ml
0.67
22
200
41
163
2.65
7.30
5.4
4.1
25.97
24.53
mmol/l
1.40
41
156
22
62
3.67
6.94
3.0
3.9
3.63
4.30
e9/l
0.74
22
62
17
28
6.25
6.83
15.3
10.0
0.66
0.64
mmol/l
0.16
17
28
22
63
3.61
6.79
3.0
4.1
51.45
56.49
%
0.95
22
63
181
1277
1.67
6.52
6.5
3.5
36.54
40.71
ng/l
0.16
118
802
33
125
2.76
6.46
2.4
1.7
—
—
—
0
0
22
67
3.39
6.21
1.1
1.3
—
—
—
0
0
135
892
1.71
6.17
3.5
3.0
1820.76
1249.44
ng/l
0.52
109
749
28
100
2.91
6.10
1.5
1.4
252.67
297.33
ug/g
0.52
18
56
14
21
6.83
6.07
1.2
1.1
—
—
—
0
0
142
955
1.69
6.06
1.5
1.3
1.94
1.60
u/ml
0.13
40
271
147
1006
1.66
5.85
6.0
3.7
0.00
0.01
estimate
0.80
49
372
151
1043
1.65
5.78
3.8
3.3
7.55
7.81
mmol/l
0.26
134
899
126
832
1.69
5.72
5.7
3.7
1.01
1.02
kg/l
1.10
15
111
30
116
2.69
5.66
1.6
2.0
—
—
—
0
0
12
16
7.66
5.66
1.3
1.2
—
—
—
0
0
22
72
3.15
5.56
2.1
1.5
—
—
—
0
0
22
72
3.15
5.56
2.1
1.5
—
—
—
0
0
98
612
1.75
5.42
1.3
1.3
4.53
8.50
u/ml
0.56
33
246
48
236
2.15
5.37
2.2
1.6
—
—
—
0
0
50
251
2.11
5.31
7.7
4.7
5.36
5.08
kpa
1.06
50
240
15
34
4.52
4.78
2.3
1.5
—
—
—
0
0
46
235
2.06
4.68
8.2
4.9
3.04
1.43
mmol/l
1.71
34
172
45
230
2.05
4.57
1.3
1.2
—
40.02
—
0
12
234
1865
1.49
4.49
5.8
3.5
0.00
0.00
estimate
0.50
59
405
28
120
2.41
4.33
1.3
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
84
2.70
4.29
2.1
3.0
0.35
0.31
u/ml
—
8
45
19
67
2.91
4.27
4.9
2.4
15.82
16.06
%
0.10
13
31
28
121
2.39
4.26
1.3
1.2
—
—
—
0
0
15
46
3.33
4.22
3.4
1.5
89.65
90.54
%
0.37
15
46
19
69
2.82
4.06
1.3
1.5
—
—
—
0
0
17
58
3.00
4.05
1.4
1.4
12357.00
6596.50
e6/l
0.33
11
40
308
2625
1.47
4.03
4.7
3.1
50.95
43.42
u/l
0.59
291
2489
21
81
2.66
4.02
2.0
3.1
77.14
29.83
mg/l
0.47
16
63
21
81
2.66
4.02
2.0
3.1
44.61
57.76
mg/l
0.31
16
63
11
22
5.09
4.02
1.5
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
22
5.09
4.02
1.3
1.2
—
—
—
0
0
230
1858
1.45
3.96
7.6
4.9
0.00
0.00
estimate
0.50
54
375
387
3464
1.58
3.94
6.5
4.5
1.82
2.22
mu/l
0.59
366
3210
120
855
1.54
3.84
2.6
2.2
—
—
—
0
0
55
321
1.80
3.81
1.5
1.3
59.68
156.00
iu/ml
2.11
20
132
23
96
2.47
3.78
1.4
1.6
—
—
—
0
0
218
1761
1.43
3.67
2.8
2.6
—
—
—
0
0
13
35
3.79
3.61
1.2
1.1
—
—
—
0
0
230
1881
1.42
3.60
5.7
3.5
0.00
0.01
estimate
0.50
51
360
29
138
2.17
3.57
1.4
1.3
—
—
—
0
0
16
57
2.87
3.55
1.5
1.6
—
—
—
0
0
18
69
2.67
3.51
1.6
1.4
—
—
—
0
0
40
217
1.92
3.48
1.5
1.4
16.03
22.07
iu/l
0.96
31
185
13
37
3.58
3.42
1.2
1.1
—
—
—
0
0
18
70
2.63
3.42
14.4
12.9
105.00
105.15
mmol/l
0.04
18
62
120
881
1.48
3.29
2.8
2.7
7051.88
5856.79
umol/l
0.11
106
778
410
3765
1.57
3.24
31.4
14.3
139.52
139.59
mmol/l
0.23
398
3649
8
15
5.40
3.20
2.6
1.3
—
—
—
0
0
16
61
2.68
3.16
1.2
1.2
2.75
4.48
u/ml
—
8
29
44
256
1.79
3.10
2.9
3.3
4.43
4.65
pmol/l
0.82
37
228
41
234
1.82
3.07
1.1
1.0
—
—
—
0
0
16
62
2.63
3.07
1.2
1.2
2.17
5.05
u/ml
—
6
21
8
16
5.06
3.06
2.3
1.4
45.31
61.97
ug/l
—
8
16
14
51
2.80
3.01
1.4
1.5
—
—
—
0
0
21
94
2.29
3.01
2.7
2.9
—
—
—
0
0
409
3774
1.53
2.95
31.6
14.4
3.95
3.96
mmol/l
0.46
398
3648
21
96
2.24
2.87
1.5
1.6
—
—
—
0
0
5
6
8.40
2.75
1.4
1.0
—
—
—
0
0
411
3810
1.51
2.75
28.2
12.8
20.12
22.25
mg/l
0.94
345
2962
372
3387
1.42
2.71
29.8
15.5
14.52
14.58
%
0.09
366
3336
20
92
2.22
2.71
3.0
1.5
—
—
—
0
0
6
10
6.06
2.70
1.2
1.0
84.67
95.60
%
—
6
10
10
29
3.50
2.70
1.0
1.0
—
—
—
0
0
31
169
1.89
2.70
2.2
1.7
—
—
—
0
0
43
260
1.72
2.68
3.5
2.8
63.23
71.43
ml/min/173m2
0.55
22
105
116
882
1.41
2.60
2.1
1.6
—
—
—
0
0
23
115
2.05
2.55
1.2
1.7
—
256.00
—
0
5
31
174
1.83
2.48
2.2
1.7
—
—
—
0
0
16
71
2.30
2.37
1.6
1.7
—
—
—
0
0
7
17
4.16
2.36
1.6
3.8
51.29
122.12
nmol/l
—
7
17
15
65
2.35
2.33
1.5
1.7
—
—
—
0
0
15
65
2.35
2.33
1.5
1.7
—
—
—
0
0
52
344
1.57
2.31
8.2
3.1
—
—
—
0
0
16
72
2.26
2.30
4.4
1.9
0.84
0.83
nmol/l
0.02
16
61
10
34
2.98
2.29
1.3
1.1
—
—
—
0
0
8
23
3.52
2.28
1.9
1.9
—
—
—
0
0
5
9
5.60
2.22
1.2
1.1
—
—
—
0
0
5
9
5.60
2.22
1.2
1.2
—
—
—
0
0
12
48
2.54
2.20
1.6
1.5
—
—
—
0
0
27
154
1.80
2.08
1.3
1.4
6.63
9.31
u/l
1.10
21
129
5
10
5.04
2.07
2.2
2.1
17.40
16.41
umol/l
—
5
10
5
10
5.04
2.07
1.4
1.4
—
—
—
0
0
5
10
5.04
2.07
1.4
1.3
—
—
—
0
0
5
10
5.04
2.07
1.0
1.2
—
—
—
0
0
12
50
2.44
2.04
1.2
1.2
—
—
—
0
0
176
1479
1.30
2.00
6.3
3.6
—
—
—
0
0
12
51
2.39
1.96
1.7
1.2
67.24
0.50
nmol/l
0.47
12
45
61
434
1.46
1.96
2.2
1.9
—
—
—
0
0
10
39
2.60
1.95
2.4
2.2
—
—
—
0
0
10
39
2.60
1.95
1.6
2.1
1.40
3.38
u/field
—
5
16
8
27
2.99
1.94
1.3
3.8
—
—
—
0
0
18
92
1.99
1.92
1.3
1.2
—
—
—
0
0
94
727
1.36
1.89
2.5
2.2
—
—
—
0
0
12
52
2.34
1.89
1.3
1.6
—
—
—
0
0
11
46
2.42
1.86
1.7
1.7
—
—
—
0
0
11
46
2.42
1.86
1.7
1.7
—
—
—
0
0
352
3249
1.30
1.84
6.5
5.2
39.59
39.28
mmol/mol
0.20
333
3062
7
23
3.07
1.80
1.3
3.1
—
—
—
0
0
13
60
2.20
1.79
1.3
1.6
—
—
—
0
0
13
60
2.20
1.79
1.0
1.1
—
—
—
0
0
49
344
1.47
1.70
2.2
1.8
—
—
—
0
0
86
669
1.35
1.67
2.5
2.0
—
—
—
0
0
6
19
3.18
1.66
1.7
1.1
—
—
—
0
0
8
31
2.61
1.66
1.3
1.1
—
—
—
0
0
8
31
2.61
1.66
1.3
1.5
—
—
—
0
0
11
49
2.27
1.64
1.4
1.6
—
—
—
0
0
7
26
2.72
1.58
1.4
1.2
—
—
—
0
0
6
20
3.02
1.58
3.7
2.3
40600.00
34680.25
ug/l
—
6
20
6
20
3.02
1.58
2.3
2.3
24.17
26.35
umol/l
—
6
20
6
20
3.02
1.58
1.0
1.2
—
—
—
0
0
43
602
0.69
1.57
2.7
2.9
0.58
0.78
ug/l
1.40
28
362
15
78
1.95
1.56
1.4
2.0
—
—
—
0
0
5
15
3.36
1.52
1.0
1.3
—
—
—
0
0
5
15
3.36
1.52
3.4
2.3
0.33
1.43
ug/l
—
5
15
7
27
2.62
1.52
1.3
1.4
87.29
70.33
umol/l
—
7
27
11
51
2.18
1.51
1.0
1.1
—
—
—
0
0
5
16
3.15
1.44
1.6
3.4
167.00
213.06
u/l
—
5
16
418
3991
1.34
1.43
14.4
9.3
25.30
25.72
u/l
0.19
410
3849
304
2798
1.23
1.42
4.1
3.4
—
—
—
0
0
9
41
2.22
1.37
1.3
1.8
—
—
—
0
0
19
113
1.71
1.33
1.5
1.6
0.00
0.05
iu/ml
—
6
22
34
235
1.48
1.31
2.7
2.3
3151.95
3790.57
u/l
0.09
11
106
6
24
2.52
1.30
2.8
2.0
—
—
—
0
0
8
34
2.37
1.29
1.1
1.8
—
—
—
0
0
8
34
2.37
1.29
1.1
1.8
—
—
—
0
0
8
34
2.37
1.29
1.1
1.8
—
—
—
0
0
112
936
1.26
1.29
4.7
3.9
13.41
10.97
mg/mmol
0.25
76
616
9
44
2.06
1.27
1.2
1.6
—
—
—
0
0
36
255
1.44
1.24
1.5
1.3
—
—
—
0
0
9
45
2.02
1.24
1.8
1.2
—
—
—
0
0
13
225
0.57
1.22
1.5
1.4
—
—
—
0
0
9
167
0.53
1.21
1.4
1.6
—
—
—
0
0
6
26
2.32
1.19
2.7
3.3
—
—
—
0
0
11
57
1.95
1.18
1.3
1.3
—
—
—
0
0
5
20
2.51
1.15
1.2
1.6
—
—
—
0
0
17
104
1.66
1.10
1.4
1.1
—
—
—
0
0
5
21
2.39
1.09
1.2
1.6
—
—
—
0
0
8
41
1.97
1.09
1.3
3.1
2.60
3.66
nmol/l
—
8
41
13
75
1.75
1.03
1.3
1.2
—
—
—
0
0
5
22
2.29
1.03
1.2
1.5
—
—
—
0
0
17
107
1.61
1.01
1.2
1.4
—
—
—
0
0
23
330
0.68
1.00
1.5
1.5
—
—
—
0
0
6
27
2.24
0.93
1.5
1.1
—
—
—
0
0
6
28
2.16
0.92
1.5
1.1
—
—
—
0
0
16
102
1.59
0.91
1.2
1.4
197.70
251.22
u/ml
—
10
57
30
399
0.74
0.86
1.7
1.6
—
—
—
0
0
68
813
0.81
0.86
3.5
4.1
26.03
21.17
%
1.11
25
355
16
104
1.56
0.85
1.6
1.3
—
—
—
0
0
88
1023
0.83
0.85
4.1
4.6
1.66
2.58
ug/l
1.48
80
903
6
32
1.89
0.82
1.3
1.2
—
—
—
0
0
60
717
0.81
0.77
1.7
1.4
—
—
—
0
0
366
3524
1.16
0.69
5.1
4.0
5.95
5.83
mmol/l
0.90
344
3231
13
191
0.67
0.68
1.5
1.5
—
—
—
0
0
7
43
1.64
0.67
1.1
1.4
—
—
—
0
0
13
86
1.53
0.66
1.3
1.5
—
—
—
0
0
5
28
1.79
0.66
1.4
1.3
189.28
168.94
pmol/l
—
5
28
6
35
1.72
0.58
1.0
1.2
—
—
—
0
0
8
125
0.63
0.55
1.5
1.5
—
—
—
0
0
46
387
1.21
0.55
21.5
6.2
—
—
—
0
0
12
170
0.70
0.54
1.3
1.4
—
—
—
0
0
12
170
0.70
0.54
1.3
1.4
—
—
—
0
0
12
170
0.70
0.54
1.3
1.4
—
—
—
0
0
12
170
0.70
0.54
1.3
1.4
—
—
—
0
0
10
66
1.53
0.53
1.6
1.1
—
11.22
—
0
5
6
40
1.51
0.51
1.2
1.4
—
—
—
0
0
6
40
1.51
0.51
1.0
1.6
—
—
—
0
0
6
40
1.51
0.51
1.2
1.4
—
—
—
0
0
9
64
1.41
0.51
1.7
1.7
—
—
—
0
0
6
41
1.47
0.50
1.2
1.4
—
—
—
0
0
6
41
1.47
0.50
1.2
1.4
—
—
—
0
0
6
41
1.47
0.50
1.2
1.4
—
—
—
0
0
10
143
0.69
0.48
1.7
1.6
—
—
—
0
0
12
85
1.42
0.47
1.3
1.2
—
—
—
0
0
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
16
123
1.31
0.41
5.9
6.9
1.44
1.42
mg/l
0.04
16
112
5
34
1.48
0.40
1.0
1.7
—
—
—
0
0
11
80
1.38
0.38
1.3
1.6
209.64
219.36
pmol/l
0.09
11
75
11
80
1.38
0.38
1.1
1.2
—
1.03
—
0
6
17
137
1.25
0.32
1.2
2.2
—
—
—
0
0
21
175
1.21
0.30
1.8
1.3
305.00
254.51
miu/ml
—
9
89
353
3600
0.93
0.28
4.5
4.0
4.46
4.65
mmol/l
3.11
335
3374
356
3490
1.07
0.27
21.1
11.4
89.13
86.42
ml/min/173m2
1.17
294
2817
12
95
1.27
0.26
1.3
1.2
0.62
2.48
u/ml
—
7
54
8
67
1.20
0.26
1.3
1.1
—
—
—
0
0
9
74
1.22
0.25
1.1
1.4
—
—
—
0
0
5
40
1.25
0.22
1.2
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
340
3456
0.95
0.20
4.1
3.7
1.40
1.27
mmol/l
1.71
318
3210
0
14
0.00
0.20
0.0
1.3
—
7.19
—
0
14
6
50
1.20
0.20
1.3
1.1
13.09
12.28
u/l
—
6
45
11
90
1.23
0.19
2.6
1.9
10.58
10.38
mg/l
0.04
11
82
353
3581
0.95
0.18
4.3
4.0
1.36
1.45
mmol/l
3.63
333
3340
10
82
1.22
0.17
1.1
1.2
—
—
—
0
0
95
911
1.05
0.15
1.7
1.7
1.49
1.38
mmol/l
0.51
90
775
430
4269
1.06
0.13
38.1
18.7
255.04
252.17
e9/l
0.41
423
4167
18
161
1.12
0.13
2.1
1.9
—
—
—
0
0
430
4271
1.06
0.12
38.8
18.7
39.47
40.23
%
1.84
400
4047
362
3656
0.96
0.12
4.9
4.4
2.61
2.77
mmol/l
3.06
343
3408
430
4274
1.05
0.11
38.1
18.7
4.42
4.52
e12/l
3.74
422
4163
430
4278
1.04
0.08
38.4
18.8
132.06
135.47
g/l
5.19
423
4217
30
317
0.94
0.08
2.7
3.8
3.01
45.46
ug/l
0.98
23
253
13
142
0.91
0.06
1.8
1.4
—
—
—
0
0
14
152
0.92
0.06
1.4
1.4
—
—
—
0
0
14
129
1.09
0.05
2.7
1.8
—
—
—
0
0
13
123
1.06
0.01
3.5
3.2
17.46
1526.74
u/ml
0.72
13
104
14
135
1.04
0.00
2.9
2.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
5.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
5
58
0.86
-0.00
1.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
65.67
—
0
6
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_SOMNOLENCE – Somnolence
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).